Sprycel Tablets 50mg from Bristol-Myers Squibb contains Dasatinib hydrate, a tyrosine kinase inhibitor used to treat Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic leukemia (ALL). It is supplied as 50mg 1 tablet with YJ code 4291020F2023.
Sprycel Tablets 50mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
